These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37429907)

  • 1. Human FcγRIIIa activation on splenic macrophages drives dengue pathogenesis in mice.
    Yamin R; Kao KS; MacDonald MR; Cantaert T; Rice CM; Ravetch JV; Bournazos S
    Nat Microbiol; 2023 Aug; 8(8):1468-1479. PubMed ID: 37429907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dengue virus neutralization is modulated by IgG antibody subclass and Fcgamma receptor subtype.
    Rodrigo WW; Block OK; Lane C; Sukupolvi-Petty S; Goncalvez AP; Johnson S; Diamond MS; Lai CJ; Rose RC; Jin X; Schlesinger JJ
    Virology; 2009 Nov; 394(2):175-82. PubMed ID: 19833371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis.
    Bloemendaal FM; Levin AD; Wildenberg ME; Koelink PJ; McRae BL; Salfeld J; Lum J; van der Neut Kolfschoten M; Claassens JW; Visser R; Bentlage A; D'Haens GRAM; Verbeek JS; Vidarsson G; van den Brink GR
    Gastroenterology; 2017 Nov; 153(5):1351-1362.e4. PubMed ID: 28756234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection.
    Chan CYY; Low JZH; Gan ES; Ong EZ; Zhang SL; Tan HC; Chai X; Ghosh S; Ooi EE; Chan KR
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31533998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-dengue virus nonstructural protein 1 antibodies contribute to platelet phagocytosis by macrophages.
    Wan SW; Yang YW; Chu YT; Lin CF; Chang CP; Yeh TM; Anderson R; Lin YS
    Thromb Haemost; 2016 Mar; 115(3):646-56. PubMed ID: 26632672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection.
    Wang M; Yang F; Huang D; Huang Y; Zhang X; Wang C; Zhang S; Zhang R
    Front Cell Infect Microbiol; 2017; 7():157. PubMed ID: 28536674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection.
    Ramadhany R; Hirai I; Sasaki T; Ono K; Ramasoota P; Ikuta K; Kurosu T
    Antiviral Res; 2015 Dec; 124():61-8. PubMed ID: 26522769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of infectious dengue virus-antibody immune complex in vivo in marmosets (Callithrix jacchus) after passive transfer of anti-dengue virus monoclonal antibodies and infection with dengue virus.
    Moi ML; Ami Y; Shirai K; Lim CK; Suzaki Y; Saito Y; Kitaura K; Saijo M; Suzuki R; Kurane I; Takasaki T
    Am J Trop Med Hyg; 2015 Feb; 92(2):370-6. PubMed ID: 25548383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cells.
    Ly MHP; Moi ML; Vu TBH; Tun MMN; Saunders T; Nguyen CN; Nguyen AKT; Nguyen HM; Dao TH; Pham DQ; Nguyen TTT; Le TQM; Hasebe F; Morita K
    BMC Infect Dis; 2018 Jan; 18(1):31. PubMed ID: 29321001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
    Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
    Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody fucosylation predicts disease severity in secondary dengue infection.
    Bournazos S; Vo HTM; Duong V; Auerswald H; Ly S; Sakuntabhai A; Dussart P; Cantaert T; Ravetch JV
    Science; 2021 Jun; 372(6546):1102-1105. PubMed ID: 34083490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis.
    Gan ES; Ting DH; Chan KR
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):111-119. PubMed ID: 27796143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DENV-specific IgA contributes protective and non-pathologic function during antibody-dependent enhancement of DENV infection.
    Wegman AD; Waldran MJ; Bahr LE; Lu JQ; Baxter KE; Thomas SJ; Waickman AT
    PLoS Pathog; 2023 Aug; 19(8):e1011616. PubMed ID: 37639455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcγ receptors.
    Syenina A; Jagaraj CJ; Aman SA; Sridharan A; St John AL
    Elife; 2015 Mar; 4():. PubMed ID: 25783751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How antibodies alter the cell entry pathway of dengue virus particles in macrophages.
    Ayala-Nunez NV; Hoornweg TE; van de Pol DP; Sjollema KA; Flipse J; van der Schaar HM; Smit JM
    Sci Rep; 2016 Jul; 6():28768. PubMed ID: 27385443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancy in dengue virus neutralizing antibody titers between plaque reduction neutralizing tests with Fcgamma receptor (FcgammaR)-negative and FcgammaR-expressing BHK-21 cells.
    Moi ML; Lim CK; Kotaki A; Takasaki T; Kurane I
    Clin Vaccine Immunol; 2010 Mar; 17(3):402-7. PubMed ID: 20042518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.
    Beltramello M; Williams KL; Simmons CP; Macagno A; Simonelli L; Quyen NT; Sukupolvi-Petty S; Navarro-Sanchez E; Young PR; de Silva AM; Rey FA; Varani L; Whitehead SS; Diamond MS; Harris E; Lanzavecchia A; Sallusto F
    Cell Host Microbe; 2010 Sep; 8(3):271-83. PubMed ID: 20833378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection.
    Wegman AD; Fang H; Rothman AL; Thomas SJ; Endy TP; McCracken MK; Currier JR; Friberg H; Gromowski GD; Waickman AT
    Front Immunol; 2021; 12():777672. PubMed ID: 34899736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
    Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
    J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.